Percutaneous biopsy achieves 90–95% diagnostic yield for solid tumors with coaxial technique. Master the access planning, needle selection, and radiation safety protocols.

Percutaneous Biopsy: 7-Step Protocol for Diagnostic Accuracy

Introduction

Percutaneous biopsy under image guidance has revolutionized tissue diagnosis, enabling histopathological and molecular characterization of suspicious lesions without the morbidity of open surgical biopsy [1]. Core needle biopsy (CNB) using automated spring-loaded devices provides architectural tissue preservation, allowing immunohistochemistry and next-generation sequencing that cytology alone cannot deliver [2].

The choice of imaging guidance—ultrasound, CT, or CT-fluoroscopy—depends on lesion location, size, and visibility [4]. The coaxial technique, in which an introducer needle is placed at the lesion margin and multiple core samples are obtained through it, has become the standard of care, minimizing pleural or peritoneal transgression and reducing the risk of tract seeding to negligible levels [3].

Indications and clinical applications

Percutaneous biopsy is indicated for any suspicious mass requiring histopathological confirmation before definitive therapy [1]. In oncology, tissue diagnosis guides treatment selection, particularly when molecular profiling for targeted agents is anticipated [2]. Common applications include lung nodules, liver lesions, renal masses, pancreatic tumors, lymphadenopathy, bone lesions, and soft tissue masses [6].

Infectious disease indications include culture of suspicious fluid collections, necrotic lymph nodes, and cavitary lung lesions [5]. Fine needle aspiration is preferred when cytology alone is sufficient (e.g., thyroid nodules, simple cysts), while core needle biopsy is mandatory when histological architecture and immunohistochemistry are required (e.g., lymphoma, sarcoma, desmoid tumors) [7].

Imaging guidance modality selection

Ultrasound is the preferred guidance modality for superficial, sonographically visible lesions including thyroid nodules, superficial lymph nodes, breast masses, and accessible hepatic or renal lesions [4]. Real-time visualization allows dynamic needle tracking, avoidance of vascular structures with Doppler, and rapid confirmation of needle tip position [8].

CT guidance is essential for deep thoracic, abdominal, retroperitoneal, and bone lesions [1]. Use 2.5–5 mm slice thickness for localization and 1–2 mm for needle placement verification [9]. CT-fluoroscopy offers real-time guidance but delivers higher radiation doses and should be reserved for mobile targets or difficult trajectories [10].

MRI guidance is available in specialized centers for lesions best visualized on MRI (e.g., prostate, breast, brain), though cost and availability limit widespread use [11]. PET/CT fusion can guide biopsy of metabolically active but morphologically subtle lesions [12].

Equipment and needle selection

Fine needle aspiration uses 22–25G Chiba needles for cytologic sampling [1]. Core needle biopsy employs 14–20G automated spring-loaded biopsy guns that capture a cylindrical tissue core [2]. For architectural preservation and molecular testing, 14–18G needles are preferred; 18–20G is acceptable when smaller caliber is necessary to minimize bleeding risk [13].

The coaxial technique uses a 17–19G introducer needle placed at the lesion margin, through which an 18–20G core needle is advanced for multiple samples [3]. This approach reduces pleural or peritoneal transgressions, minimizes patient discomfort, and allows sampling of different lesion areas without repositioning [3]. Bone biopsy requires 11–13G bone biopsy needles with a trephine or drill tip [14].

Step-by-step biopsy protocol

Step 1: Pre-procedure planning

Review all available imaging to define lesion size, vascularity, and relationship to critical structures. Plan the shortest safe trajectory that avoids vessels, bowel, pleura, and nerves [1]. For lung lesions, identify the optimal intercostal space and patient position (prone, supine, or lateral decubitus) to minimize parenchymal traversal [6].

Step 2: Patient preparation

Verify coagulation status (INR <1.5, platelets >50,000/μL) [15]. Hold anticoagulants per protocol: warfarin 5 days, direct oral anticoagulants 2–3 days, clopidogrel 5 days [15]. Aspirin may be continued for most biopsies. Obtain informed consent including risks of hemorrhage, pneumothorax, infection, and tract seeding [16].

Step 3: Image-guided localization

Position the patient and acquire planning images. Mark the skin entry site. Administer local anesthesia (1–2% lidocaine) along the planned tract [1]. For deep lesions, create a pilot hole with a scalpel to facilitate needle passage through resistant skin and fascia.

Step 4: Introducer placement (coaxial technique)

Advance the coaxial introducer needle under real-time guidance to the lesion margin. Confirm position with imaging. For CT guidance, a single scan with the needle in place is usually sufficient; for CT-fluoroscopy, monitor continuously [10].

Step 5: Core sampling

Advance the core needle through the introducer into the lesion. Fire the biopsy gun to capture tissue. Withdraw the core needle and expel the specimen into formalin or transport medium [13]. Obtain 2–4 cores for histology and additional samples in saline or RPMI for molecular testing if indicated [2].

Step 6: Post-biopsy imaging

Perform immediate post-procedure imaging to detect complications. For lung biopsies, obtain a chest X-ray at 1–2 hours [6]. For liver and kidney biopsies, a limited CT scan may be obtained if hemorrhage is suspected [17].

Step 7: Recovery and discharge

Observe the patient for 2–4 hours. Monitor vital signs and the biopsy site. For lung biopsies, obtain a follow-up chest X-ray before discharge [6]. Provide written instructions regarding signs of bleeding or infection.

Radiation dose reduction and personnel safety

CT-guided biopsies are among the most common interventional radiology procedures, yet they contribute significantly to cumulative occupational radiation exposure [18]. A single CT-guided lung biopsy may require 10–20 CT acquisitions, delivering operator hand doses of 50–200 μSv and eye doses of 10–50 μSv depending on case complexity and patient body habitus [19].

Low-dose CT protocols are essential for biopsy guidance. Reduce tube current (mAs) to the minimum level that maintains adequate lesion visualization, increase pitch, and use iterative reconstruction to compensate for noise [19]. Limit scan length to the region of interest and avoid full-chest or full-abdomen acquisitions when only a small field is needed [20].

SATPro 0.5 mm Pb leaded gloves reduce hand dose by up to 60% during needle manipulation under CT-fluoroscopy [21]. SATPro 0.75 mm Pb leaded eyewear with anti-fog coating protects the lens of the eye from scatter radiation during lateral and oblique CT projections [22]. For thyroid protection, SATPro wraparound thyroid shields provide 0.5 mm Pb equivalent attenuation, reducing dose by over 90% [23].

SATPro disposable sterile scatter-shield drapes placed over the patient’s lateral thorax or abdomen attenuate side scatter by approximately 65%, creating a protected corridor for the operator’s hands and forearms during repeated needle adjustments [24]. SATPro table-mounted lead drapes positioned at the CT gantry edge block downward scatter, further reducing ambient exposure [25].

For high-volume biopsy services, SATPro wireless real-time dosimetry badges enable continuous monitoring of operator exposure, with automated alerts when dose rates exceed institutional thresholds [26]. This technology allows immediate feedback, enabling operators to modify technique or positioning mid-procedure to maintain ALARA compliance.

Diagnostic yield and specimen adequacy

Core needle biopsy achieves diagnostic yields of 90–95% for solid tumors across all organ systems [2]. The yield is highest for large, homogeneous lesions and lowest for necrotic or cystic masses where viable tissue is sparse [13]. FNA cytology provides adequate material in 70–85% of cases but is insufficient for subtyping lymphoma, grading sarcoma, or performing comprehensive molecular profiling [7].

On-site cytopathology assessment improves adequacy rates by allowing immediate evaluation and additional sampling if the specimen is nondiagnostic [27]. Rapid on-site evaluation (ROSE) is particularly valuable for pancreatic, lung, and lymph node biopsies where repeat procedures are costly and morbid [28].

Complications and management

Hemorrhage is the most common complication, occurring in 1–5% of cases depending on the organ biopsied [1]. Most bleeding is self-limiting, but large hematomas may require transfusion or angioembolization [17]. Pneumothorax complicates 15–30% of lung biopsies, with 5–10% requiring chest tube placement [6].

Tumor seeding along the needle tract is exceedingly rare (<0.01%) with coaxial technique [3]. Infection is rare but preventable with strict sterile technique. Vasovagal reactions occur in 1–2% of patients and respond to atropine and intravenous fluids [16]. Organ-specific complications include hematuria (renal), bile leak (hepatic), and pancreatitis (pancreatic) [1].

Post-procedure care and results

Observe the patient for 2–4 hours with serial vital signs and site checks [1]. For lung biopsies, obtain a chest X-ray at 1–2 hours and before discharge [6]. For liver and kidney biopsies, monitor blood pressure and hematocrit if bleeding is suspected [17].

Pathology results are typically available within 3–5 days for histology and 7–14 days for molecular testing [2]. Communicate results to the referring clinician promptly and coordinate multidisciplinary tumor board discussion when malignancy is confirmed [29].

Conclusion

Percutaneous biopsy is the foundation of modern oncologic diagnosis, enabling tissue acquisition with minimal morbidity and maximal diagnostic yield. The coaxial technique, appropriate needle selection, and meticulous imaging guidance ensure that clinicians obtain adequate material for histology, immunohistochemistry, and molecular profiling in a single session. As the volume of CT-guided biopsies continues to grow, radiation safety must remain a central concern. SATPro’s comprehensive shielding portfolio—from leaded gloves and eyewear to wireless dosimetry—protects operators during the high-volume biopsy workflows that define contemporary interventional radiology practice. Mastery of percutaneous biopsy technique and safety protocols is essential for every interventional radiologist committed to delivering precise, patient-centered diagnostic care.